US Patent 7514460 Benzazole analogues and uses thereof
Patent 7514460 was granted and assigned to 4SC AG on April, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+190 characters)
Article
Patent abstract
The present invention relates to N2-heteroaryl-benzazole-2,(5 or 6)-diamine derivatives and compositions thereof as protein kinase inhibitors for the treatment of e.g. cancer.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07514460 Benzazole analogues and uses thereof US Patent 7514460 Benzazole analogues and uses thereof
Infobox
Patent Number
0751446000
Patent Number
751446000
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 3 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075144600
Date of Patent
April 7, 2009
0Patent Application Number
113038540
Date Filed
December 15, 2005
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075144600
Date of Patent
April 7, 2009
0Patent Application Number
113038540
Date Filed
December 15, 2005
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07514460 Benzazole analogues and uses thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07514460
Date of patent
April 7, 2009
Patent application number
11303854
Date Filed
December 15, 2005
Patent primary examiner
Find more entities like US Patent 7514460 Benzazole analogues and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
